Media coverage
12
Media coverage
Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet PipelineReview Country Spain Date 9/17/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet PR Newswire Country United States Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet PR Newswire Country United States Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet PR Newswire Country United States Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet India Pharma News Country India Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet BioSpace Country United States Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet Manchester Times Country United States Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet Tullahoma News Country United States Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet Herald Chronicle Country United States Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet Elk Valley Times Country United States Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet Erie News Now Country United States Date 9/16/19 Persons GEORGE THOMPSONIII Title Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Media name/outlet ABC6.com Country United States Date 9/16/19 Persons GEORGE THOMPSONIII